Chapter CSB 2

CSB 2.011 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register December 2024 No. 828, eff. 12-16-24; renumbered to CSB 2.011 under s. 13.92 (4) (b) 1., Stats., Register April 2025 No. 832.

CSB 2.012 CSB 2.012 Addition of 7 Fentanyl Related Substances to Schedule I.

CSB 2.012(1) (1) Section 961.14 (2) (nd) 8m, 12p, 16h, 16q, 16r, 17d, and 18m are created to read:

961.14 (2) (nd) 8m. Beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide);

12p. Meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

16h. Ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);

16q. Ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);

16r. Para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide;

17d. Para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide);

18m. Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophen-2-carboxamide);

History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2025 No. 832, eff. 3-31-25; renumbered from 2.005 under s. 13.92 (4) (b) 1., Stats., Register April 2025 No. 832.

APPENDIX

CSB 2.012 Note Note: This Appendix contains actions of the Controlled Substances Board that were made prior to April 3, 2023, which were numbered ss. CSB 2.01 to 2.99.

CSB 2.012 Note CSB 2.01 Addition of methaqualone to schedule II. The substance known as methaqualone is hereby added to s. 161.16, Stats., schedule II in sub. (6) which subsection is hereby created.

CSB 2.012 Note Note: See Chapter 206, Laws of 1981 sections 29 and 31.

CSB 2.012 History History: Cr. Register, June, 1973, No. 210, eff. 7-1-73.

CSB 2.012 Note CSB 2.02 Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III. The substances known as benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine are hereby added to s. 161.18, Stats., schedule III in sub. (2m) (a), (b), (c), (d) and (e) respectively, which subsections are created to read:

CSB 2.012 Note (2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:

CSB 2.012 Note (a) Benzphetamine

CSB 2.012 Note (b) Chlorphentermine

CSB 2.012 Note (c) Clortermine

CSB 2.012 Note (d) Mazindol

CSB 2.012 Note (e) Phendimetrazine

CSB 2.012 History History: Cr. Register, October, 1973, No. 214, eff. 11-1-73.

CSB 2.012 Note CSB 2.03 Addition of fenfluramine to schedule IV. The substance known as fenfluramine is hereby added to s. 161.20, Stats., schedule IV in sub. (2m) (a), which subsection is hereby created to read:

CSB 2.012 Note (2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:

CSB 2.012 Note (a) Fenfluramine:

CSB 2.012 Note Note: See Chapter 206, Laws of 1981 section 47.

CSB 2.012 History History: Cr. Register, October, 1973, No. 214, eff. 11-1-73.

CSB 2.012 Note CSB 2.04 Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III. (1) Subsection (7) of s. 161.16, Stats., schedule II is hereby created to read as follows:

CSB 2.012 Note (7) Unless excepted under federal regulations or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

CSB 2.012 Note (a) Amobarbital

CSB 2.012 Note (b) Pentobarbital

CSB 2.012 Note (c) Secobarbital

CSB 2.012 Note (2) Paragraphs (m) and (n) of sub. (3), s. 161.18, Stats., schedule III, are hereby created to read as follows:

CSB 2.012 Note (m) Unless excepted under federal regulations, any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

CSB 2.012 Note (n) Unless excepted under federal regulations, any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.

CSB 2.012 Note Note: See Chapter 206, Laws of 1981 sections 30 and 37.

CSB 2.012 History History: Cr. Register, July, 1974, No. 223, eff. 8-1-74.

CSB 2.012 Note CSB 2.05 Addition of drotebanol to schedule I. The substance known as drotebanol is hereby added to s. 161.14, Stats., schedule I in sub. (3), par. (hm), which paragraph is created to read:

CSB 2.012 Note (hm) Drotebanol;

CSB 2.012 History History: Cr. Register, July, 1974, No. 223, eff. 8-1-74.

CSB 2.012 Note CSB 2.06 Addition of pentazocine to schedule III. Subsection (4m) of s. 161.18, Stats., schedule III is hereby created to read as follows:

CSB 2.012 Note (4m) Pentazocine.

CSB 2.012 Note Note: See Chapter 6, Laws of 1981 sections 2 and 3.

CSB 2.012 History History: Cr. Register, August, 1974, No. 224, eff. 9-1-74.

CSB 2.012 Note CSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II. (1) Subsection (3) (intro.) of s. 161.14, Stats., schedule I is amended to read:

CSB 2.012 Note (3) Unless specifically excepted or listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:

CSB 2.012 Note (2) Paragraph (em) of sub. (3), s. 161.16, Stats., schedule II, is hereby created to read:

CSB 2.012 Note (em) Etorphine hydrochloride;

CSB 2.012 Note Note: See Chapter 206, Laws of 1981 sections 6, 20 and 24.

CSB 2.012 History History: Cr. Register, August, 1974, No. 224, eff. 9-1-74.

CSB 2.012 Note CSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV. (1) Paragraph (d) of sub. (2), s. 161.16, Stats., schedule II is hereby created to read:

CSB 2.012 Note (d) Concentrate of poppy straw (the crude extract of Poppy Straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).

CSB 2.012 Note (2) Paragraph (n) of sub. (2) of s. 161.20, Stats., schedule IV is hereby created to read:

CSB 2.012 Note (n) Mebutamate

CSB 2.012 Note (3) Paragraph (b) of sub. (2m) of s. 161.20, Stats., schedule IV is hereby created to read:

CSB 2.012 Note (b) Pemoline:

CSB 2.012 Note Note: See Chapter 206, Laws of 1981 sections 20, 22 and 45.

CSB 2.012 History History: Cr. Register, February, 1976, No. 242, eff. 3-1-76.

CSB 2.012 Note CSB 2.09 Additions to schedules IV and I. (1) Addition of benzodiazepine substances to schedule IV. Paragraphs (cm), (cn), (cp), (cr), (em) and (hm) of sub. (2), s. 161.20, Stats., schedule IV are hereby created to read:

CSB 2.012 Note (cm) Chlordiazepoxide

CSB 2.012 Note (cn) Clonazepam

CSB 2.012 Note (cp) Chlorazepate

CSB 2.012 Note (cr) Diazepam

CSB 2.012 Note (em) Flurazepam

CSB 2.012 Note (hm) Oxazepam

CSB 2.012 Note (2) Addition of the thiophene analog of phencyclidine to schedule I. Paragraph (u) of sub. (4), s. 161.14, Stats., schedule I is hereby created to read:

CSB 2.012 Note (u) Thiophene analog of phencyclidine

CSB 2.012 Note (3) Addition of mecloqualone to schedule I. Subsection (5) and par. (a) of s. 161.14, Stats., schedule I are hereby created to read:

CSB 2.012 Note (5) Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

CSB 2.012 Note (a) Mecloqualone

CSB 2.012 Note (4) Addition of difenoxin to schedule I. Paragraph (hg) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read:

CSB 2.012 Note (hg) Difenoxin

CSB 2.012 Note (5) Addition of 2,5 dimethoxyamphetamine, 4-romo-2,5 dimethoxyamphetamine and 4-methoxyamphetamine to schedule I. Paragraphs (v), (w) and (x) of sub. (4), s. 161.14, Stats., schedule I are hereby created to read:

CSB 2.012 Note (v) 2,5-dimethoxyamphetamine

CSB 2.012 Note (w) 4-bromo-2,5-dimethoxyamphetamine

CSB 2.012 Note (x) 4-methoxyamphetamine

CSB 2.012 Note Note: See Chapter 206, Laws of 1981 sections 13 and 15.

CSB 2.012 History History: Cr. Register, April, 1976, No. 244, eff. 5-1-76.

CSB 2.012 Note CSB 2.10 Addition of propiram to schedule I. Paragraph (wn) of sub. (2), s. 161.14, Stats., schedule I is hereby created to read:

CSB 2.012 Note (wn) Propiram

CSB 2.012 History History: Cr. Register, August, 1976, No. 248, eff. 9-1-76.

CSB 2.012 Note CSB 2.11 Renumbering and addition to schedule IV of diethylpropion and phentermine. Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:

CSB 2.012 Note (b) Fenfluramine

CSB 2.012 Note Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read:

CSB 2.012 Note (a) Diethylpropion

CSB 2.012 Note Paragraph (b) of sub. (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read:

CSB 2.012 Note (c) Pemoline